News Announcement

Eiko Lifesciences: Board Meeting Outcome for Approved Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026 Along With Limited Review Report Issued By The Statutory Auditors Of The Company.

Pursuant to the Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) and amendments thereto this is to inform that the Meeting of the Board of Directors of the Company held today i.e. on Wednesday 12th August 2026 which commenced at 1:00 PM and concluded at 01:40 PM Board inter-alia approved and taken on record the following:1. Approved Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026 along with Limited Review Report issued by the Statutory Auditors of the Company.

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.